PYZCHIVA Trademark

Trademark Overview


On Monday, February 27, 2023, a trademark application was filed for PYZCHIVA with the United States Patent and Trademark Office. The USPTO has given the PYZCHIVA trademark a serial number of 79366850. The federal status of this trademark filing is REGISTERED as of Tuesday, December 5, 2023. This trademark is owned by SAMSUNG BIOEPIS CO., LTD.. The PYZCHIVA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of hematological, autoimmune, inflammatory, respiratory, and transplantation-related diseases and disorders; pharmaceutical preparations for the treatment of generalized myasthenia gravis; pharmaceutical preparations for use in hematology; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for treating respiratory diseases; pharmaceutical preparations for the treatment of ulcerative colitis; antidiabetic preparations; human vaccine preparations; pharmaceutical preparations, namely, pharmaceutical preparations, biological formulations, biological preparations, antibody formulations and protein formulations for immunoregulation and for treatment of immunologic disorders, autoimmune diseases, inflammatory diseases, arthritis, cancer, tumor, central nervous system disorders and metabolic diseases; anti-inflammatory preparation...
pyzchiva

General Information


Serial Number79366850
Word MarkPYZCHIVA
Filing DateMonday, February 27, 2023
Status700 - REGISTERED
Status DateTuesday, December 5, 2023
Registration Number7232809
Registration DateTuesday, December 5, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 19, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of hematological, autoimmune, inflammatory, respiratory, and transplantation-related diseases and disorders; pharmaceutical preparations for the treatment of generalized myasthenia gravis; pharmaceutical preparations for use in hematology; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for treating respiratory diseases; pharmaceutical preparations for the treatment of ulcerative colitis; antidiabetic preparations; human vaccine preparations; pharmaceutical preparations, namely, pharmaceutical preparations, biological formulations, biological preparations, antibody formulations and protein formulations for immunoregulation and for treatment of immunologic disorders, autoimmune diseases, inflammatory diseases, arthritis, cancer, tumor, central nervous system disorders and metabolic diseases; anti-inflammatory preparations; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for tumor treatment; pharmaceutical preparations for the treatment of diseases of the metabolic system; medicated pharmaceutical preparations for skin treatment; pharmaceutical preparations for psoriasis treatment; pharmaceutical preparations for the treatment of psoriatic arthritis; pharmaceutical preparations for the treatment of Crohn's disease

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 12, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSAMSUNG BIOEPIS CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressKR

Party NameSAMSUNG BIOEPIS CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR

Party NameSAMSUNG BIOEPIS CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Tuesday, April 2, 2024FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, March 7, 2024FINAL DISPOSITION NOTICE SENT TO IB
Thursday, March 7, 2024FINAL DISPOSITION PROCESSED
Tuesday, March 5, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, December 5, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 5, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, September 19, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 19, 2023PUBLISHED FOR OPPOSITION
Monday, September 18, 2023NOTIFICATION PROCESSED BY IB
Wednesday, August 30, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 30, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 30, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 22, 2023REFUSAL PROCESSED BY IB
Thursday, August 17, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 16, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 15, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 15, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 3, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, August 3, 2023REFUSAL PROCESSED BY MPU
Tuesday, June 27, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, June 26, 2023NON-FINAL ACTION WRITTEN
Thursday, June 22, 2023ASSIGNED TO EXAMINER
Tuesday, April 18, 2023APPLICATION FILING RECEIPT MAILED
Wednesday, April 12, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 11, 2023LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, April 6, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB